Vir Biotechnology Inc. Insider Trading

VIR

Last 12 months

Insiders sold $2.94M and bought nothing on the open market.

All of the selling was scheduled in advance under 10b5-1 plans. The last open-market buy by an executive or director was in Mar 2023.

Net open-market

−$2.94M

0 buys · 25 sales

Under a 10b5-1 plan

100%

of the value sold

Insiders who bought / sold

0 / 7

executives and directors

Last open-market buy

Mar 2023

Mar 1, 2023

Get an email when VIR's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Nov 2 – 3	Vanina De Verneuil EVP, General Counsel, Corp Sec	Sold10b5-1 plan 2 parts	3,750	$11.18 average	42K	3.3%	Form 4
Jun 1	Janet Napolitano Director	Sold10b5-1 plan	3,200	$9.45	30K	13%	Form 4
Jun 1	Brent Sabatini SVP, Chief Accounting Officer	Sold10b5-1 plan	379	$9.45	4K	0.6%	Form 4
May 1	Vicki L Sato Director	Sold10b5-1 plan	22,000	$10.05	221K	2.0%	Form 4
Apr 6	Marianne De Backer President and CEO	Sold10b5-1 plan	72,559	$9.16	665K	6.8%	Form 4
Apr 1	Vicki L Sato Director	Sold10b5-1 plan	22,000	$9.07	200K	2.0%	Form 4
Mar 23	Brent Sabatini SVP, Chief Accounting Officer	Sold10b5-1 plan	7,711	$9.12	70K	11%	Form 4
Mar 2	Vicki L Sato Director	Sold10b5-1 plan 2 parts	22,000	$9.50 average	209K	1.9%	Form 4
Feb 24 – 25	Mark Eisner EVP and Chief Medical Officer	Sold10b5-1 plan 2 parts	3,505	$9.69 average	34K	2.2%	Form 4
Feb 24 – 25	Vanina De Verneuil EVP, General Counsel, Corp Sec	Sold10b5-1 plan 2 parts	16,817	$9.77 average	164K	13%	Form 4
Feb 24	Vicki L Sato Director	Sold10b5-1 plan 2 parts	42,377	$9.75 average	413K	3.6%	Form 4
Feb 24	Brent Sabatini SVP, Chief Accounting Officer	Sold10b5-1 plan	1,430	$9.53	14K	2.0%	Form 4
Feb 24	Jason O'Byrne EVP & Chief Financial Officer	Sold10b5-1 plan	1,634	$9.53	16K	1.0%	Form 4
Feb 24	Marianne De Backer Chief Executive Officer	Sold10b5-1 plan	14,762	$9.53	141K	1.4%	Form 4
Feb 23	Brent Sabatini SVP, Chief Accounting Officer	Sold10b5-1 plan	1,829	$7.45	14K	2.5%	Form 4
Feb 23	Jason O'Byrne EVP & Chief Financial Officer	Sold10b5-1 plan	2,089	$7.45	16K	1.3%	Form 4
Feb 23	Mark Eisner EVP and Chief Medical Officer	Sold10b5-1 plan	2,089	$7.45	16K	1.3%	Form 4
Feb 23	Vanina De Verneuil EVP, General Counsel, Corp Sec	Sold10b5-1 plan	4,445	$7.45	33K	3.3%	Form 4
Feb 23	Marianne De Backer Chief Executive Officer	Sold10b5-1 plan	19,039	$7.45	142K	1.7%	Form 4
Feb 13	Brent Sabatini SVP, Chief Accounting Officer	Sold10b5-1 plan	1,530	$7.79	12K	3.1%	Form 4
Feb 2	Vicki L Sato Director	Sold10b5-1 plan	22,000	$7.71	170K	1.9%	Form 4
Jan 2	Vicki L Sato Director	Sold10b5-1 plan	22,000	$5.93	130K	1.9%	Form 4
Dec 1, 2025	SVF Endurance (cayman) Ltd Large holder	Sold10b5-1 plan	191,854	$5.98	$1.15M	1.4%	Form 4
Dec 1, 2025	Vicki L Sato Director	Sold10b5-1 plan	22,000	$6.00	132K	1.8%	Form 4
Nov 26, 2025 – Nov 28, 2025	Softbank Vision Fund (aiv M1) L.p. Large holder	Sold10b5-1 plan 2 parts	189,431	$6.41 average	$1.21M	1.3%	Form 4
Nov 24, 2025 – Nov 25, 2025	SVF Endurance (cayman) Ltd Large holder	Sold10b5-1 plan 2 parts	463,774	$6.27 average	$2.91M	3.2%	Form 4
Nov 17, 2025	Jason O'Byrne EVP & Chief Financial Officer	Sold10b5-1 plan	6,799	$5.56	38K	5.8%	Form 4
Nov 5, 2025	Vanina De Verneuil EVP, General Counsel, Corp Sec	Sold10b5-1 plan	2,385	$5.16	12K	3.0%	Form 4
Nov 3, 2025	Vanina De Verneuil EVP and General Counsel	Sold10b5-1 plan	1,365	$5.86	8K	1.7%	Form 4
Nov 3, 2025	Vicki L Sato Director	Sold10b5-1 plan	22,000	$5.64	124K	1.8%	Form 4
Oct 28, 2025 – Oct 29, 2025	SVF Endurance (cayman) Ltd Large holder	Sold10b5-1 plan 2 parts	24,553	$6.50 average	160K	0.2%	Form 4
Oct 24, 2025 – Oct 27, 2025	SB Investment Advisers (uk) LTD Large holder	Sold10b5-1 plan 2 parts	113,099	$6.01 average	680K	0.8%	Form 4
Oct 22, 2025 – Oct 23, 2025	SB Investment Advisers (uk) LTD Large holder	Sold10b5-1 plan 2 parts	298,649	$6.07 average	$1.81M	2.0%	Form 4
Oct 20, 2025 – Oct 21, 2025	SVF Endurance (cayman) Ltd Large holder	Sold10b5-1 plan 2 parts	330,210	$6.23 average	$2.06M	2.2%	Form 4
Oct 15, 2025 – Oct 16, 2025	SVF Endurance (cayman) Ltd Large holder	Sold10b5-1 plan 2 parts	29,515	$6.08 average	180K	0.2%	Form 4
Oct 9, 2025 – Oct 10, 2025	Softbank Vision Fund (aiv M1) L.p. Large holder	Sold10b5-1 plan 2 parts	251,360	$6.14 average	$1.54M	1.6%	Form 4
Oct 7, 2025 – Oct 8, 2025	SB Investment Advisers (uk) LTD Large holder	Sold10b5-1 plan 2 parts	538,375	$5.99 average	$3.22M	3.3%	Form 4
Oct 3, 2025 – Oct 6, 2025	SVF Endurance (cayman) Ltd Large holder	Sold10b5-1 plan 2 parts	524,297	$5.58 average	$2.92M	3.1%	Form 4
Oct 1, 2025	Vicki L Sato Director	Sold10b5-1 plan	22,000	$5.84	128K	1.8%	Form 4
Sep 2, 2025	Vicki L Sato Director	Sold10b5-1 plan	22,000	$4.99	110K	1.7%	Form 4

Nov 2 – 310b5-1 plan
Vanina De Verneuil
EVP, General Counsel, Corp Sec · sold 3,750 at avg $11.18
42K
3.3% of stake
Jun 110b5-1 plan
Janet Napolitano
Director · sold 3,200 at $9.45
30K
13% of stake
Jun 110b5-1 plan
Brent Sabatini
SVP, Chief Accounting Officer · sold 379 at $9.45
4K
0.6% of stake
May 110b5-1 plan
Vicki L Sato
Director · sold 22,000 at $10.05
221K
2.0% of stake
Apr 610b5-1 plan
Marianne De Backer
President and CEO · sold 72,559 at $9.16
665K
6.8% of stake
Apr 110b5-1 plan
Vicki L Sato
Director · sold 22,000 at $9.07
200K
2.0% of stake
Mar 2310b5-1 plan
Brent Sabatini
SVP, Chief Accounting Officer · sold 7,711 at $9.12
70K
11% of stake
Mar 210b5-1 plan
Vicki L Sato
Director · sold 22,000 at avg $9.50
209K
1.9% of stake
Feb 24 – 2510b5-1 plan
Mark Eisner
EVP and Chief Medical Officer · sold 3,505 at avg $9.69
34K
2.2% of stake
Feb 24 – 2510b5-1 plan
Vanina De Verneuil
EVP, General Counsel, Corp Sec · sold 16,817 at avg $9.77
164K
13% of stake
Feb 2410b5-1 plan
Vicki L Sato
Director · sold 42,377 at avg $9.75
413K
3.6% of stake
Feb 2410b5-1 plan
Brent Sabatini
SVP, Chief Accounting Officer · sold 1,430 at $9.53
14K
2.0% of stake
Feb 2410b5-1 plan
Jason O'Byrne
EVP & Chief Financial Officer · sold 1,634 at $9.53
16K
1.0% of stake
Feb 2410b5-1 plan
Marianne De Backer
Chief Executive Officer · sold 14,762 at $9.53
141K
1.4% of stake
Feb 2310b5-1 plan
Brent Sabatini
SVP, Chief Accounting Officer · sold 1,829 at $7.45
14K
2.5% of stake
Feb 2310b5-1 plan
Jason O'Byrne
EVP & Chief Financial Officer · sold 2,089 at $7.45
16K
1.3% of stake
Feb 2310b5-1 plan
Mark Eisner
EVP and Chief Medical Officer · sold 2,089 at $7.45
16K
1.3% of stake
Feb 2310b5-1 plan
Vanina De Verneuil
EVP, General Counsel, Corp Sec · sold 4,445 at $7.45
33K
3.3% of stake
Feb 2310b5-1 plan
Marianne De Backer
Chief Executive Officer · sold 19,039 at $7.45
142K
1.7% of stake
Feb 1310b5-1 plan
Brent Sabatini
SVP, Chief Accounting Officer · sold 1,530 at $7.79
12K
3.1% of stake
Feb 210b5-1 plan
Vicki L Sato
Director · sold 22,000 at $7.71
170K
1.9% of stake
Jan 210b5-1 plan
Vicki L Sato
Director · sold 22,000 at $5.93
130K
1.9% of stake
Dec 1, 202510b5-1 plan
SVF Endurance (cayman) Ltd
Large holder · sold 191,854 at $5.98
$1.15M
1.4% of stake
Dec 1, 202510b5-1 plan
Vicki L Sato
Director · sold 22,000 at $6.00
132K
1.8% of stake
Nov 26, 2025 – Nov 28, 202510b5-1 plan
Softbank Vision Fund (aiv M1) L.p.
Large holder · sold 189,431 at avg $6.41
$1.21M
1.3% of stake
Nov 24, 2025 – Nov 25, 202510b5-1 plan
SVF Endurance (cayman) Ltd
Large holder · sold 463,774 at avg $6.27
$2.91M
3.2% of stake
Nov 17, 202510b5-1 plan
Jason O'Byrne
EVP & Chief Financial Officer · sold 6,799 at $5.56
38K
5.8% of stake
Nov 5, 202510b5-1 plan
Vanina De Verneuil
EVP, General Counsel, Corp Sec · sold 2,385 at $5.16
12K
3.0% of stake
Nov 3, 202510b5-1 plan
Vanina De Verneuil
EVP and General Counsel · sold 1,365 at $5.86
8K
1.7% of stake
Nov 3, 202510b5-1 plan
Vicki L Sato
Director · sold 22,000 at $5.64
124K
1.8% of stake
Oct 28, 2025 – Oct 29, 202510b5-1 plan
SVF Endurance (cayman) Ltd
Large holder · sold 24,553 at avg $6.50
160K
0.2% of stake
Oct 24, 2025 – Oct 27, 202510b5-1 plan
SB Investment Advisers (uk) LTD
Large holder · sold 113,099 at avg $6.01
680K
0.8% of stake
Oct 22, 2025 – Oct 23, 202510b5-1 plan
SB Investment Advisers (uk) LTD
Large holder · sold 298,649 at avg $6.07
$1.81M
2.0% of stake
Oct 20, 2025 – Oct 21, 202510b5-1 plan
SVF Endurance (cayman) Ltd
Large holder · sold 330,210 at avg $6.23
$2.06M
2.2% of stake
Oct 15, 2025 – Oct 16, 202510b5-1 plan
SVF Endurance (cayman) Ltd
Large holder · sold 29,515 at avg $6.08
180K
0.2% of stake
Oct 9, 2025 – Oct 10, 202510b5-1 plan
Softbank Vision Fund (aiv M1) L.p.
Large holder · sold 251,360 at avg $6.14
$1.54M
1.6% of stake
Oct 7, 2025 – Oct 8, 202510b5-1 plan
SB Investment Advisers (uk) LTD
Large holder · sold 538,375 at avg $5.99
$3.22M
3.3% of stake
Oct 3, 2025 – Oct 6, 202510b5-1 plan
SVF Endurance (cayman) Ltd
Large holder · sold 524,297 at avg $5.58
$2.92M
3.1% of stake
Oct 1, 202510b5-1 plan
Vicki L Sato
Director · sold 22,000 at $5.84
128K
1.8% of stake
Sep 2, 202510b5-1 plan
Vicki L Sato
Director · sold 22,000 at $4.99
110K
1.7% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch VIR, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Biological Products, (No Diagnostic Substances) · Pick stocks to compare with VIR

CompareIntrinsic value

VCELVericel Corporation

$45.48+10.68%65

ADPTAdaptive Biotechnologies Corporation

$26.71+3.53%40

IOVAIovance Biotherapeutics, Inc.

$8.70-1.47%10

VXRTVaxart Inc.

$0.40+0.00%84

IMCRImmunocore Holdings plc

$29.23-2.66%40

TWSTTwist Bioscience Corporation

$142.58+1.63%40

KRYSKrystal Biotech Inc.

$310.84+1.90%44

IBRXImmunityBio, Inc.

$8.45+1.87%30

Held by ETFs

VIR is in 58 US ETFs. The largest of them, with VIR's weight in each:

Spot a number that looks wrong? Check it in VIR's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing VIR

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.